Delivery Order SPE2DB22D9102-SPE2DB25FZN80

Award Date 10/11/24
Potential Completion Date 10/15/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $18,488.12 contract is for the supply of TRIKAFTA 100-50-75 MG/150 MG UU 84S, a pharmaceutical product, with a completion date of June 9, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, valued at $37,053.68, is for the supply of a pharmaceutical product called TRIKAFTA 100-50-75 MG/150 MG UU 84S. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, that allows DMS Pharmaceutical Group to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of TRIKAFTA 80-40-60MG/59.5MG PKT 14S, which is a specialized pharmaceutical product. The contract has a ceiling value of $37,053.68 and is a firm fixed-price delivery order with an ultimate completion date of December 22, 2023. DMS Pharmaceutical Group Inc. has a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,488.12, is for the delivery of TRIKAFTA 100-50-75 MG/150 MG UU 84S, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of February 19, 2025 and is not associated...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $73,952.48 firm fixed-price contract is for the delivery of TRIKAFTA 100-50-75 MG/150 MG medical supplies. The contract has an ultimate completion date of May 6, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of TRIKAFTA 100-50-75 MG/75MG PKT 14S, a prescription drug, with a ceiling value of $18,526.83. The contract has a firm fixed-price pricing type and runs through May 31, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The order, valued at $18,526.83, is for the delivery of TRIKAFTA 100-50-75 MG/150 MG UU 84S, a pharmaceutical drug, with a completion date of March 4, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. DMS Pharmaceutical Group Inc. holds an indefinite delivery contract, contract 4600082013 under...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $36,962.14 firm fixed-price contract is for the supply of TRIKAFTA 100-50-75 MG/150 MG, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 award is for the delivery of the pharmaceutical product TRIKAFTA 100-50-75 MG/150 MG UU 84S. This is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to provide a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, worth up to $74,107.32, is for the delivery of TRIKAFTA 100-50-75 MG/75MG PKT 14S, a pharmaceutical product, with a completion date of May 8, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. DMS Pharmaceutical Group holds a significant...
  • SPE2DB22D9102
    Indefinite Delivery Contract
  • SPE2DB22D9102-SPE2DB25FZN80
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,526.83, is for the supply of the pharmaceutical product TRIKAFTA 100-50-75 MG/75MG PKT 14S. It is a firm fixed-price contract with an ultimate completion date of October 15, 2024.

DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 1/10/25, 9:06 AM